It is a business services private limited company based in Mumbai, Maharashtra, India, established in 1984.
1984 | Mumbai, Maharashtra, India | Struck OffAmol Drug Pharma Private Limited, a struck off private limited company, was established on 20 January 1984 in Mumbai, Maharashtra, India. it holds CIN: U24239MH1984PTC031889. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.35 Cr and a paid-up capital of ₹2.35 Cr.
It upholds a compliant status. Its leadership includes Amol Jayavant Kale (Director), Ganesh Ramchandra Tandel (Director), Rohini Baburao Mandrekar (Director). Past directors included Jayavant Damodar Kale, Meera Jayavant Kale, Deepak Aghor. It holds no open charges and ₹1.11 Cr settled loans. Its latest AGM occurred on 05 September 2023, with the balance sheet filed on 31 March 2023. It is based at G-81,S Gruodaya Nagar,First Panjarpole Lane,, Mumbai, Maharashtra, 400004.
U24239MH1984PTC031889
031889
20 January 1984
₹2.35 Cr
₹2.35 Cr
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Amol Drug Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amol Jayavant Kale | Director | 25 Sep 2009 | Current |
| Ganesh Ramchandra Tandel | Director | 22 Jun 2020 | Current |
| Rohini Baburao Mandrekar | Director | 01 Aug 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 May 2020 | Past |
| Pramod Abcsdd | Director | 05 Aug 2022 | Past |
| Pramod Abcsdd | Director | 20 Mar 2014 | Past |
| Pramod Abcsdd | Additional Director | 16 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amol Drug Pharma Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 99.82% decrease. The company also saw a substantial improvement in profitability, with a 96.32% increase in profit. The company's net worth dipped by a decrease of 0.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Amol Drug Pharma had a promoter holding of 11.91% and a public holding of 88.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹11,050,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2006 | State Bank Of India | ₹1.11 Cr | Satisfied |
Explore comprehensive loan charge details -
Amol Drug Pharma has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Amol Drug Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amol Drug Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Amol Drug Pharma Private Limited last Annual general meeting of members was held on 05 Sep 2023 as per latest MCA records. was recorded as a recent event.
The activity Amol Drug Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
Rohini Baburao Mandrekar was appointed as a Director was appointed as a Director on 01 Aug 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.
Ganesh Ramchandra Tandel was appointed as a Director was appointed as a Director on 22 Jun 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
The activity Amol Jayavant Kale was appointed as a Director was appointed as a Director on 25 Sep 2009 & has been associated with this company since 16 years 2 months . was completed.
Progress on A charge registered on 07 Aug 2006 via Charge ID 10017375 with State Bank Of India was fully satisfied on 03 Jul 2009. was documented.
The CIN of Amol Drug Pharma Private Limited is U24239MH1984PTC031889.
Amol Drug Pharma Private Limited is headquartered at G-81,S Gruodaya Nagar,First Panjarpole Lane,, Mumbai, Maharashtra, 400004.
Amol Drug Pharma Private Limited was incorporated on 20 January 1984.
The current directors of Amol Drug Pharma Private Limited are
Amol Drug Pharma Private Limited is unlisted.
The authorized capital of Amol Drug Pharma Private Limited is ₹2.35 Cr, and the paid-up capital is ₹2.35 Cr.
The compliance status of Amol Drug Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX